Novartis booth at AACR 2026
Biotech

Has Novartis’ T-Charge push been overtaken by in vivo CAR-Ts?

It’s been over four years since Novartis shook up the CAR-T space with its T-Charge platform. But that’s a lifetime in the world of cell therapies.
James Waldron May 22, 2026 8:28am
Missed target failed trial trial failure

Biogen axes Denali-partnered Parkinson’s drug after phase 2 flop

May 22, 2026 6:12am
BIO - Fierce Native Ad Article BOMPrimary image - 13673700jpg

Rethinking the path to IND

Brought to you by Thermo Fisher Scientific
Magnifying glass focusing on womens health

OSE turns up the heat on ovarian cancer with phase 2 win

May 22, 2026 7:14am
Where the Promise of NAMs Meets Practice

Where the Promise of NAMs Meets Practice

Brought to you by Battelle
Top drug launches of 2026

BioAge CEO talks NLRP3 and ‘pipeline in a pill’ ambitions

May 22, 2026 10:00am
More News

Former FDA leader takes new biotech Turn—Chutes & Ladders

May 22, 2026 8:30am
Fierce Pharma

ASCO: Merck, Kelun's sac-TMT combo beats Keytruda by 65% on PFS

May 21, 2026 5:00pm

Betting on biotech: Prediction markets turn to clinical trials

May 21, 2026 10:30am

Lilly’s triple-G drug drives deep weight loss in phase 3 trial

May 21, 2026 10:27am